iNtRON Biotechnology, Inc. (048530.KQ) — Stock Score Summary

Frequently Asked Questions

What is iNtRON Biotechnology, Inc.’s (048530.KQ) StockRank?

MoatMap’s StockRank for iNtRON Biotechnology, Inc. (048530.KQ) is 24/100, with a Sell signal. It is a composite of Quality (38), Value (49), and Momentum (24) factor ranks across MoatMap’s 19,000+ stock universe.

Does iNtRON Biotechnology, Inc. have an economic moat?

iNtRON Biotechnology, Inc. (048530.KQ) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.

Is iNtRON Biotechnology, Inc. a buy, hold, or sell?

MoatMap’s current signal for iNtRON Biotechnology, Inc. (048530.KQ) is Sell, based on a StockRank of 24/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is iNtRON Biotechnology, Inc. in?

iNtRON Biotechnology, Inc. (048530.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).